S Kansoy
Overview
Explore the profile of S Kansoy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hazar V, Kansoy S, Kupesiz A, Aksoylar S, Kantar M, Yesilipek A
Bone Marrow Transplant
. 2004 Mar;
33(9):931-5.
PMID: 15034541
Cytomegalovirus (CMV) disease remains an important cause of morbidity and mortality in patients undergoing hematopoietic stem cell transplantation (HSCT). We evaluated high-dose acyclovir (HDACV) and pre-emptive ganciclovir to prevent CMV...
2.
Yilmaz D, Cetingul N, Kantar M, Oniz H, Kansoy S, Kavakli K
Pediatr Hematol Oncol
. 2003 Dec;
21(1):1-8.
PMID: 14660300
The authors aimed to investigate the efficacy of epoetin-alpha on hemoglobin levels and red cell transfusion requirement in children with both hematologic malignancy (HM, n = 27) and solid tumors...
3.
Aksoylar S, Akman S, Ozgenc F, Kansoy S
Pediatr Hematol Oncol
. 2001 Sep;
18(6):397-406.
PMID: 11554235
Tropisetron and granisetron are selective serotonin (5-HT3) antagonists that have been proven effective in the prevention of nausea and vomiting in adults and children receiving cancer chemotherapy. This prospective, randomised...
4.
Kasirga E, Isenlik S, Aksoylar S, Yaprak I, Kansoy S, Yuce G
Pediatr Int
. 2001 Feb;
42(6):642-6.
PMID: 11192521
Background: The aim of the present study was to evaluate the efficacy of treatment with recombinant interferon (IFN)-alpha2b in 12 children with chronic hepatitis B who had previously undergone therapy...
5.
Aksu N, Turker M, Erdogan H, Ozinel S, Kansoy S
Turk J Pediatr
. 2000 Apr;
41(2):225-30.
PMID: 10770662
Recently, there have been numerous reports on the use of cyclosporin A (CyA) in children with nephrotic syndrome (NS). In this prospective study, we wanted to evaluate the efficacy of...
6.
Aksu N, Yavascan O, Erdogan H, Dorak M, Kansoy S, Kozan M
Adv Perit Dial
. 2000 Jan;
14:255-7.
PMID: 10649736
The aim of this study was to evaluate systolic and diastolic cardiac functions in children treated with continuous ambulatory peritoneal dialysis (CAPD). This study included a total of 21 patients...
7.
Aksu N, Keskinoglu A, Erdogan H, Yavascan O, Mir S, Kansoy S
Adv Perit Dial
. 2000 Jan;
14:243-6.
PMID: 10649733
The purpose of this study was to evaluate whether immunologic status could predict the development of peritonitis in children on continuous ambulatory peritoneal dialysis (CAPD). Twenty-one patients (12 boys, 9...
8.
Ozcan Z, Erenel G, Aksoylar S, Kansoy S, Burak Z, Ozkilic H
Clin Nucl Med
. 1999 Aug;
24(4):267-70.
PMID: 10466525
Tc-99m sestamibi, originally developed for myocardial studies, has been used as a tumor-seeking agent. Recently, the agent also was reported to be a functional tracer to predict multidrug resistance-related p-glycoprotein...
9.
Aksit S, Caglayan S, Yaprak I, Kansoy S
Acta Paediatr Jpn
. 1997 Feb;
39(1):34-6.
PMID: 9124050
In the present study, the risk of exposure to aflatoxin in infants fed breast milk and formula was investigated. For this purpose, aflatoxin B1 (AFB1) was determined in the serum...
10.
Yaprak I, Caglayan S, Kansoy S, Ozdogru E, Bakiler A, Aydinlioglu H
Turk J Pediatr
. 1994 Jan;
36(1):43-7.
PMID: 8191607
Chronic idiopathic thrombocytopenic purpura is an autoimmune disease characterized by antibody-mediated destruction of platelets. To maintain the platelets above the symptomatic level, we administered anti-D (100 micrograms for 5 consecutive...